Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-10

FDA Approved: METHENAMINE HIPPURATE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved an original ANDA for methenamine hippurate from Zydus Lifesciences Limited, establishing this drug as a generic option for urinary tract infection …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine Hippurate (Methenamine hippurate)

Snippet

ORIG AP for METHENAMINE HIPPURATE (METHENAMINE HIPPURATE)